Work

Perinatal antibiotic exposure and risk of childhood infections: a retrospective cohort study

Year: 2025

Type: article

Abstract: Background: Epidemiological studies report associations between antibiotics given during pregnancy, childbirth, and infancy and subsequent risk for childhood infections. The specific role of intrapartum and neonatal antibiotic exposures is not well-described. Methods: Retrospective cohort study of healthy term infants through 6 years of age. The primary exposure was perinatal antibiotics, defined as intravenous intrapartum antibiotic administration during the admission for childbirth or administered to the infant ≤3 days after birth. The primary outcome was infection-related inpatient encounters. Adjusted multivariable-adjusted Cox proportional hazards and marginal means/rates models were used to investigate the association between exposure and outcome. A secondary analysis examined the association between early infant antibiotics administered during the first three months after birth, including perinatal antibiotics, and the outcome. Findings: Of 13,919 infants, 3936 (28%) had perinatal antibiotic exposure. 1294 (9.3%) children had 1619 inpatient encounters, of which 988 (61%) were infection-related. Infection-related inpatient encounters occurred in 265 (6.7%) children exposed to perinatal antibiotics, compared to 584 (5.8%) unexposed children (risk difference 1.2%, 95% CI 0.3-2.1%, p = 0.005). In multivariable-adjusted models, perinatal antibiotic exposure was not associated with infection-related inpatient encounters [Cox model: aHR 1.16, 95% CI 0.95, 1.51, p = 0.15; marginal rates/means model: aHR 1.22, 95% CI 0.98, 1.51, p = 0.08]. Early infant antibiotics were also not associated with the outcome. Interpretation: In this study of 13,919 newborns across 24 primary pediatric practices, perinatal or early infant antibiotic exposure was not associated with subsequent early childhood hospitalization for infectious diseases. Funding: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, funding (K23 HD088753) supported this study.

Source: The Lancet Regional Health - Americas

DOI: 10.1016/j.lana.2025.101264